Cytokinetics, Incorporated (CYTK) is trading at $41.72, up 11.25 percent or $4.22 during Wednesday's trading, with no apparent reason for the surge.
The stock opened at $42.01 and has moved within a range of $41.15 to $43.69 today, compared to a previous close of $37.50 on the Nasdaq. Trading volume has reached 2.95 million shares, nearly double the average of 1.65 million.
The stock's 52-week range is between $37.46 and $75.71.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.